It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 1 FA rating(s) are green whileWBA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 6 TA indicator(s) are bullish while WBA’s TA Score has 5 bullish TA indicator(s).
CVS (@Managed Health Care) experienced а -2.13% price change this week, while WBA (@Drugstore Chains) price change was -10.04% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -3.25%. For the same industry, the average monthly price growth was -0.41%, and the average quarterly price growth was +2.76%.
The average weekly price growth across all stocks in the @Drugstore Chains industry was -0.88%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was -0.69%.
CVS is expected to report earnings on Apr 30, 2025.
WBA is expected to report earnings on Mar 27, 2025.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
@Drugstore Chains (-0.88% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
CVS | WBA | CVS / WBA | |
Capitalization | 100B | 18.7B | 535% |
EBITDA | 18.2B | -11.23B | -162% |
Gain YTD | 25.636 | 8.467 | 303% |
P/E Ratio | 12.33 | 32.85 | 38% |
Revenue | 358B | 145B | 247% |
Total Cash | 11.5B | 668M | 1,722% |
Total Debt | 79.4B | 33.6B | 236% |
CVS | WBA | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 97 | |
PRICE GROWTH RATING 1..100 | 47 | 58 | |
P/E GROWTH RATING 1..100 | 34 | 63 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (3) in the Drugstore Chains industry is in the same range as WBA (5). This means that CVS’s stock grew similarly to WBA’s over the last 12 months.
CVS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as WBA (100). This means that CVS’s stock grew similarly to WBA’s over the last 12 months.
CVS's SMR Rating (80) in the Drugstore Chains industry is in the same range as WBA (97). This means that CVS’s stock grew similarly to WBA’s over the last 12 months.
CVS's Price Growth Rating (47) in the Drugstore Chains industry is in the same range as WBA (58). This means that CVS’s stock grew similarly to WBA’s over the last 12 months.
CVS's P/E Growth Rating (34) in the Drugstore Chains industry is in the same range as WBA (63). This means that CVS’s stock grew similarly to WBA’s over the last 12 months.
CVS | WBA | |
---|---|---|
RSI ODDS (%) | 2 days ago76% | 2 days ago75% |
Stochastic ODDS (%) | 2 days ago60% | 2 days ago66% |
Momentum ODDS (%) | 2 days ago67% | 2 days ago85% |
MACD ODDS (%) | 2 days ago60% | 2 days ago76% |
TrendWeek ODDS (%) | 2 days ago58% | 2 days ago73% |
TrendMonth ODDS (%) | 2 days ago55% | 2 days ago55% |
Advances ODDS (%) | 10 days ago61% | 2 days ago57% |
Declines ODDS (%) | 4 days ago60% | 4 days ago70% |
BollingerBands ODDS (%) | 2 days ago66% | 2 days ago61% |
Aroon ODDS (%) | 2 days ago51% | 2 days ago45% |